Rachel Rubin

Dr. Rachel Rubin is a board-certified urologist and a leading expert on sexual health, particularly for women. She discusses the often-ignored complexities of women’s sexual health, hormonal changes during menopause, and the critical need for personalized hormone replacement therapy (HRT). Dr. Rubin clarifies misconceptions surrounding HRT and emphasizes the benefits of local vaginal therapies. She also highlights the significant health risks of menopause, including osteoporosis and cognitive decline, advocating for improved awareness and education in this field.

Dr. Rachel S. Rubin, a board-certified urologist and sexual medicine expert, transforms menopause care with her innovative insights. She discusses the evolution of guidelines post-WHI, addressing misconceptions surrounding hormone therapy. Rachel emphasizes the importance of individualized treatment options and the need to balance clinician fears with patient education. She also explores practical applications for vaginal and systemic therapies, including testosterone use in women, and shares a stepwise approach for managing menopause symptoms effectively.

Exploring topics from the first annual Sex Symposium in NYC, including challenges in women's health innovation, empowering women through personal stories, and the importance of health and pleasure in sexual wellness. Discusses VIP dinner experiences, commitment to women's health, and supporting research with innovative products.

Dr. Rachel Rubin, a urologist and sexual medicine specialist, sheds light on how hormonal changes negatively impact women's urinary and vaginal health. She emphasizes the prevalence of recurrent UTIs and advocates for vaginal hormone therapies as a vital preventive measure. The discussion touches on the significant evidence supporting vaginal estrogen's safety and efficacy, the overlooked role of androgens, and the barriers preventing proper hormone therapy access. Informed patients and clinicians can transform approaches to menopause care and enhance quality of life.

In a groundbreaking discussion, Dr. Marty McCary, an FDA commissioner, and Dr. Rachel Rubin, a menopause and HRT expert, delve into the pivotal removal of boxed warnings on hormone replacement therapy (HRT). They unveil the positive implications for women's health, debunk myths that have caused unnecessary fear, and stress the long-term benefits of HRT, including reducing heart disease and osteoporosis risks. The conversation highlights the need for better clinician education and informed consent, empowering women to make knowledgeable health choices.